Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer
Prostate cancer (PCa) is the most common noncutaneous cancer in men worldwide. One of its major treatments is androgen deprivation therapy, but PCa frequently relapses as aggressive castration resistant local tumors and distal metastases. Hence, the development of novel agents or treatment modalitie...
Main Authors: | Pei-Yi Wu, Yueh-Chien Lin, Yuan-Li Huang, Wei-Min Chen, Chien-Chin Chen, Hsinyu Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/11/413 |
Similar Items
-
Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
by: Jie Zhang, et al.
Published: (2020-02-01) -
Lysophosphatidic Acid Receptor 4 Activation Augments Drug Delivery in Tumors by Tightening Endothelial Cell-Cell Contact
by: Kazuhiro Takara, et al.
Published: (2017-08-01) -
Effects of Gintonin-enriched fraction on the gene expression of six lysophosphatidic receptor subtypes
by: Rami Lee, et al.
Published: (2021-09-01) -
Regulation of Tumor Immunity by Lysophosphatidic Acid
by: Sue Chin Lee, et al.
Published: (2020-05-01) -
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
by: Eleanna Kaffe, et al.
Published: (2019-10-01)